- Home
- HYFT vs TIL Comparison
HYFT vs TIL Comparison
Compare HYFT & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYFT | TIL |
|---|---|---|
| Founded | 1983 | 2018 |
| Country | United States | United States |
| Employees | 102 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.9M | 54.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HYFT | TIL |
|---|---|---|
| Price | $1.34 | $8.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $5.00 | ★ $125.00 |
| AVG Volume (30 Days) | ★ 161.4K | 20.7K |
| Earning Date | 03-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.06 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $29.18 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.99 | $5.67 |
| 52 Week High | $3.00 | $42.75 |
Technical Indicators
Market Signals| Indicator | HYFT | TIL |
|---|---|---|
| Relative Strength Index (RSI) | 57.22 | 48.27 |
| Support Level | $1.02 | $8.07 |
| Resistance Level | $1.48 | $9.03 |
| Average True Range (ATR) | 0.09 | 0.41 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 65.15 | 58.62 |
Price Performance
Historical ComparisonAbout HYFT MindWalk Holdings Corp.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.